Shares of other companies:
April 29, 2024 Tesla, Baidu Join Forces for Self-Driving Tech in China
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Facing A Liquidity Crunch; Dilution Ahead?
April 29, 2024
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
RPRX Stock News and Mentions of Royalty Pharma plc Stocktwits
Updated: April 30, 2024 (10:17)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Royalty Pharma Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Royalty Pharma plc (RPRX).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Royalty Pharma stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Royalty Pharma plc (RPRX)
April 19, 2024 (12:15) / "GlobeNewswire" (by Royalty Pharma plc)
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
NEW YORK, April 19, 2024 ( GLOBE NEWSWIRE ) -- Royalty Pharma plc ( Nasdaq: RPRX ) today announced that it will report its first quarter 2024 financial results on Thursday, May 9, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 ...
In Article Trend: Neutral
April 19, 2024 (12:15) / "Benzinga" (by Globe Newswire)
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024 - Royalty Pharma ( NASDAQ:RPRX )
NEW YORK, April 19, 2024 ( GLOBE NEWSWIRE ) -- Royalty Pharma plc RPRX today announced that it will report its first quarter 2024 financial results on Thursday, May 9, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m.
In Article Trend: Somewhat-Bullish
April 17, 2024 (12:15) / "GlobeNewswire" (by Royalty Pharma plc)
Royalty Pharma Declares Second Quarter 2024 Dividend
NEW YORK, April 17, 2024 ( GLOBE NEWSWIRE ) -- The board of directors of Royalty Pharma plc ( Nasdaq: RPRX ) has approved the payment of a dividend for the second quarter of 2024 of $0.21 per Class A ordinary share.
In Article Trend: Somewhat-Bullish
April 15, 2024 (10:20) / "Zacks Commentary" (by Zacks Equity Research)
Should You Invest in the iShares U.S. Pharmaceuticals ETF ( IHE ) ?
Sector ETF report for ...
In Article Trend: Neutral
April 11, 2024 (06:18) / "Stocknews.com" (by Defense World Staff)
StockNews.com Upgrades Royalty Pharma ( NASDAQ:RPRX ) to Buy
Royalty Pharma ( NASDAQ:RPRX - Get Free Report ) was upgraded by research analysts at StockNews.com from a "hold" rating to a "buy" rating in a note issued to investors on Thursday.
In Article Trend: Somewhat-Bullish
April 4, 2024 (15:15) / "Benzinga" (by Benzinga Insights)
Looking Into Royalty Pharma's Recent Short Interest - Royalty Pharma ( NASDAQ:RPRX )
Royalty Pharma's RPRX short percent of float has fallen 3.91% since its last report. The company recently reported that it has 12.65 million shares sold short, which is 2.95% of all regular shares that are available for trading.
In Article Trend: Somewhat-Bullish
March 30, 2024 (06:18) / "Stocknews.com" (by Defense World Staff)
Royalty Pharma ( NASDAQ:RPRX ) Lifted to "Buy" at StockNews.com
Royalty Pharma ( NASDAQ:RPRX - Get Free Report ) was upgraded by StockNews.com from a "hold" rating to a "buy" rating in a note issued to investors on Saturday. RPRX has been the topic of several other research reports.
In Article Trend: Somewhat-Bullish
March 23, 2024 (09:32) / "Stocknews.com" (by Defense World Staff)
Royalty Pharma ( NASDAQ:RPRX ) Downgraded by StockNews.com
StockNews.com downgraded shares of Royalty Pharma ( NASDAQ:RPRX - Free Report ) from a buy rating to a hold rating in a research report report published on Friday morning.
In Article Trend: Somewhat-Bullish
March 6, 2024 (09:28) / "Stocknews.com" (by Defense World Staff)
Royalty Pharma ( NASDAQ:RPRX ) Upgraded at StockNews.com
StockNews.com upgraded shares of Royalty Pharma ( NASDAQ:RPRX - Free Report ) from a hold rating to a buy rating in a research note published on Tuesday. RPRX has been the subject of a number of other research reports.
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website